Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
Organic Letters|July 28, 2007
A general copper-catalyzed sulfonylation of arylboronic acidsAnirban Kar, Iliyas Ali Sayyed, Wei Fun Lo, et al.
Sarcoma|December 27, 2013
Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcomaJuan Martin-Liberal, Salma Alam, Anastasia Constantinidou, et al.
Blood Advances|July 8, 2026
AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomesNicolas Basty, Martin F Kaiser, Charlotte Pawlyn, et al.
Clinical Nuclear Medicine|July 11, 2025
Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysisMickael Tordjman, Murat Yuce, Amine Geahchan, et al.
BMJ Open|October 26, 2022
MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myelomaJessica Kendall, Andrew Hall, Sadie Roberts, et al.
Eclinicalmedicine|April 28, 2025
Genetic predisposition in sarcomas: clinical implications and managementElizabeth A Connolly, Kjetil Boye, Sylvie Bonvalot, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcomaAlexandra Pender, Elizabeth J Davis, Dharmisha Chauhan, et al.
Haematologica|February 8, 2006
The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myelomaMartin Kaiser, Ivana Zavrski, Jan Sterz, et al.
Annals of Human Genetics|February 16, 2019
Regions of homozygosity as risk factors for multiple myelomaMolly Went, Amit Sud, Ni Li, et al.
AJR. American Journal of Roentgenology|October 20, 2021
Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT CriteriaMathias Meyer, Peter Hohenberger, Daniel Overhoff, et al.
Pageof 28